| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |